MoneyWorks4Me

Venus Remedies - Quaterly Results

29 May 2023 Evaluate
The revenue for the March 2023 quarter is pegged at Rs. 1485.30 millions, about 15.35% up against Rs. 1287.70 millions recorded during the year-ago period.The Net Profit of the company reported a remarkable increase of 211.57% to Rs. 75.40  millions  from Rs. 24.20 millions in previous same quarter.Operating profit for the quarter ended March 2023 rose to 242.70 millions as compared to 97.80 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 1485.30 1287.70 15.35 5376.60 5767.10 -6.77 5376.60 5767.10 -6.77
Other Income 32.40 24.70 31.17 101.70 84.30 20.64 101.70 84.30 20.64
PBIDT 242.70 97.80 148.16 717.00 772.50 -7.18 717.00 772.50 -7.18
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 242.70 97.80 148.16 717.00 772.50 -7.18 717.00 772.50 -7.18
Depreciation 80.60 73.60 9.51 313.70 325.80 -3.71 313.70 325.80 -3.71
PBT 162.10 24.20 569.83 403.30 446.70 -9.72 403.30 446.70 -9.72
TAX 86.70 0.00 0.00 113.70 -43.20 -363.19 113.70 -43.20 -363.19
Deferred Tax 86.70 0.00 0.00 113.70 -43.20 -363.19 113.70 -43.20 -363.19
PAT 75.40 24.20 211.57 289.60 489.90 -40.89 289.60 489.90 -40.89
Equity 133.70 133.70 0.00 133.70 133.70 0.00 133.70 133.70 0.00
PBIDTM(%) 16.34 7.59 115.15 13.34 13.39 -0.44 13.34 13.39 -0.44
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..